Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PCSK7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | HMCN1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | BCAP29 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | PRPF4B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ASB2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CAV1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SWT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PKLR | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | LINC00998 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ANKH | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |